Haemonetics Corporation (HAE) Gross Margin
- Gross margin · 12 months: Value 59.03%; Formula and calculation Gross profit / revenue. Period ending 2026-06-27..
Gross margin
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 59.03% | Gross profit / revenue. Period ending 2026-06-27. $798.14M ÷ $1.35B × 100 ≈ 59.03% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 798.14M USD | Gross Profit |
| Revenue | 1.35B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 553.87M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-27 | $798.14M | $1.35B | $553.87M | 59.03% |
| 2026-03-28 | $787.59M | $1.33B | $546.44M | 59.04% |
| 2025-12-27 | $782.42M | $1.32B | $535.85M | 59.35% |
| 2025-09-27 | $773.59M | $1.33B | $554.26M | 58.26% |
| 2025-06-28 | $766.28M | $1.35B | $579.77M | 56.93% |
| 2025-03-29 | $748.96M | $1.36B | $611.87M | 55.04% |
| 2024-12-28 | $731.81M | $1.37B | $641.70M | 53.28% |
| 2024-09-28 | $716.13M | $1.36B | $645.09M | 52.61% |
| 2024-06-29 | $699.21M | $1.33B | $634.69M | 52.42% |
| 2024-03-30 | $691.55M | $1.31B | $617.51M | 52.83% |
| 2023-12-30 | $671.89M | (m) | $598.29M | (m) |
| 2023-09-30 | $652.73M | (m) | $586.50M | (m) |
| 2023-07-01 | $640.10M | (m) | $578.43M | (m) |
| 2023-04-01 | $615.10M | (m) | $553.56M | (m) |
| 2022-12-31 | $595.16M | (m) | $534.09M | (m) |
| 2022-10-01 | $575.02M | (m) | $508.70M | (m) |
| 2022-07-02 | $539.68M | (m) | $486.45M | (m) |
| 2022-04-02 | $505.50M | (m) | $487.69M | (m) |
| 2022-01-01 | $451.00M | (m) | $502.23M | (m) |
| 2021-10-02 | $432.69M | (m) | $501.13M | (m) |
| 2021-07-03 | $415.89M | (m) | $487.52M | (m) |
| 2021-04-03 | $397.84M | (m) | $472.63M | (m) |
| 2020-12-26 | $429.59M | (m) | $454.34M | (m) |
| 2020-09-26 | $437.38M | (m) | $465.14M | (m) |
| 2020-06-27 | $458.64M | (m) | $486.97M | (m) |
| 2020-03-28 | $484.51M | (m) | $503.97M | (m) |
| 2019-12-28 | $482.17M | (m) | $517.12M | (m) |
| 2019-09-28 | $465.29M | (m) | $522.38M | (m) |
| 2019-06-29 | $450.20M | (m) | $526.49M | (m) |
| 2019-03-30 | $417.54M | (m) | $550.04M | (m) |
| 2018-12-29 | $410.71M | (m) | (m) | (m) |
| 2018-09-29 | $410.83M | (m) | (m) | (m) |
| 2018-06-30 | $403.49M | (m) | (m) | (m) |
| 2018-03-31 | $411.91M | (m) | (m) | (m) |
| 2017-12-30 | $389.63M | (m) | (m) | (m) |
| 2017-09-30 | $379.42M | (m) | (m) | (m) |
| 2017-07-01 | $379.10M | (m) | (m) | (m) |
| 2017-04-01 | $378.49M | (m) | (m) | (m) |
| 2016-12-31 | $385.61M | (m) | (m) | (m) |
| 2016-10-01 | $393.38M | (m) | (m) | (m) |
| 2016-07-02 | $394.43M | (m) | (m) | (m) |
| 2016-04-02 | $405.91M | (m) | (m) | (m) |
| 2015-12-26 | $425.06M | (m) | (m) | (m) |
| 2015-09-26 | $427.86M | (m) | (m) | (m) |
| 2015-06-27 | $430.68M | (m) | (m) | (m) |
| 2015-03-28 | $434.42M | $910.37M | (m) | 47.72% |
| 2014-12-27 | $441.49M | (m) | (m) | (m) |
| 2014-09-27 | $451.46M | (m) | (m) | (m) |
| 2014-06-28 | $463.23M | (m) | (m) | (m) |
| 2014-03-29 | $468.37M | $938.51M | (m) | 49.91% |
| 2013-12-28 | $476.06M | (m) | (m) | (m) |
| 2013-09-28 | $467.55M | (m) | (m) | (m) |
| 2013-06-29 | $449.43M | (m) | (m) | (m) |
| 2013-03-30 | $428.13M | $891.99M | (m) | 48.00% |
| 2012-12-29 | $399.60M | (m) | (m) | (m) |
| 2012-09-29 | $382.42M | (m) | (m) | (m) |
| 2012-06-30 | $370.61M | (m) | (m) | (m) |
| 2012-03-31 | $369.24M | $727.84M | (m) | 50.73% |
| 2011-12-31 | $362.13M | (m) | (m) | (m) |
| 2011-10-01 | $359.69M | (m) | (m) | (m) |
| 2011-07-02 | $357.49M | (m) | (m) | (m) |
| 2011-04-02 | $355.21M | (m) | (m) | (m) |
| 2011-01-01 | (m) | (m) | (m) | (m) |
| 2010-10-02 | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) |
| 2010-04-03 | $337.48M | (m) | (m) | (m) |
| 2009-12-26 | (m) | (m) | (m) | (m) |
| 2009-09-26 | (m) | (m) | (m) | (m) |
| 2009-06-27 | (m) | (m) | (m) | (m) |
| 2009-03-28 | $308.17M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |